Global Medical Head, Obesity, Injectables Portfolio

Are you ready to be at the forefront of medical innovation? As the Global Medical Head, Obesity, Injectables Portfolio, this role plays a pivotal part in crafting the future of obesity care. This is a chance to use deep expertise to make a real impact on patients' lives. Join us in our mission to transform the patient journey, from prevention to diagnosis, and beyond.

In this dynamic role, the Global Medical Head, Obesity for our injectables portfolio (SARA and GLP1/GCGR agonists) provides medical leadership across the entire product lifecycle. The role leads a team of talented medical professionals, advises on Research and Development investment decisions, drives pre-launch scientific efforts, and accelerates evidence-based healthcare changes in the real world. Networking and influencing skills are crucial to facilitate cross-functional collaboration and drive innovation.

Ready to take on this challenge? This highly experienced Medical Affairs leader brings validated vision and impact to shape product and disease area strategy, build capability, drive product launches and life cycle management, provide strategic direction for evidence generation, education and publication, and engage extensively externally to further the scientific leadership of AstraZeneca.

Reporting directly to the Medical Head of Weight Management and T2D within Medical Affairs Cardiovascular Renal Metabolism (CVRM), this critical strategic leadership position sits on global product and brand teams and leads a global medical team. A strong network with regions and countries will be developed, pairing unique medical expertise with insight from markets, healthcare professionals, patients and health systems to design and implement world-class medical strategies globally.

Through this leadership, the role helps build a world-class obesity capability within AstraZeneca, enabling outstanding product launches, practice-defining clinical studies, generation of real-world evidence, transformation of health systems and, ultimately, acceleration of population health.

Responsibilities

• Provide enterprise leadership by building and leading the global CVRM BPM obesity team, partnering with key stakeholders internally and externally to deliver an integrated medical strategy for the injectables portfolio.

• Set strategic vision and direction by developing, integrating and implementing global strategic medical plans that span early development through launch and life cycle management for SARA and GLP1/GCGR agonists.

• Drive external scientific engagement by defining and driving an ambitious engagement agenda with key external authorities, scientific societies, patient organisations and health system partners to shape healthcare practice in obesity.

• Lead launch excellence, performance management and life-cycle optimisation by defining clear benchmarks, identifying new opportunities in disease state understanding, and ensuring competitive, evidence-based medical plans that anticipate current and future needs.

• Develop evidence generation strategy across clinical development, real-world evidence and health economics to address unmet needs in obesity management, advise guidelines and support access decisions.

• Guide scientific communication, education and publication planning to ensure robust dissemination of data that advises clinical practice and positions AstraZeneca as a trusted scientific partner.

• Act as a key partner across Research and Development and Commercial functions to influence investment decisions, advise brand strategies and ensure alignment between scientific innovation and real-world medical practice.

• Champion cross-functional collaboration across geographies, enabling knowledge sharing, capability building and consistent execution of global medical strategies at regional and local levels.

Essential Skills/Experience

• Sophisticated Scientific Degree (MBBS, PharmD, PhD, or MD) or equivalent education with substantial clinical or research experience relevant to obesity or cardiometabolic disease.

• A minimum of 7 years of experience in the pharmaceutical industry, ideally in Medical Affairs, working at the country and global/regional level.

• Experience leading the global CVRM BPM obesity team, partnering with key stakeholders internally and externally.

• Experience with the development, integration, and implementation of strategic medical plans at a global level.

• Experience driving a bold external engagement agenda, forming strategic alliances and partnerships that can shape healthcare and best practices in the obesity therapy area.

• Experience driving innovation and setting key performance indicators (KPIs) to shape disease state understanding, surface new opportunities, and deliver strategic medical plans that are bold for current and future needs